Диссертация (1174283), страница 21
Текст из файла (страница 21)
D. How We Treat Chronic Graft-versus-Host Disease./Mary E.D. Flowers, J. Martin Paul. // Blood—2015. — Vol.125—P.606-61554.Garbutcheon-Singh, KB. Phototherapy for the treatment of cutaneous graftversus host disease./ KB Garbutcheon-Singh, P.Fernández-Peñas//Australas JDermatol—2014.
— Vol. 56 —P. 93-9955.Giampetruzzi, AR. Association of dermoscopic profiles of telangiectaseswith nailfold videocapillaroscopic patterns in patients with systemic sclerosis / ARGiampetruzzi, C Mondino, A Facchiano et al.//J Rheumatol. —2013. —Vol. 40 (9)—P.1630-163256.Gottlöber, P. Chronic cutaneous sclerodermoid graft-versus-host disease:evaluation by 20-MHz sonography./ P Gottlöber, U Leiter, W Friedrich et al.// JEur Acad Dermatol Venereol. — 2003. —Vol.17(4) —P.402-407.57.Guan,Y.F.Peroxisomeproliferator-activatedreceptors(PRAP):Noveltherapeutic targets in renal disease./ Y.F.Guan, M.D.
Breyer //Kidney int. —2001. — Vol.60(1) —P.14-3014858.Gunes, G. Late Onset and Protracted Course of Steroid Refractory ChronicGraft-versus-Host Disease./ G Gunes, H Demiroglu, H Goker et al.//Case Reportsin Hematology —2015. —Vol.2015 —Article ID 692175.59.Haeusermann, P.
Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation. / P Haeusermann, EKump, A Rovó et al.// Dermatology —2009.—Vol.219(1) —P.32-34.60.Hahn, T. Significant improvement in survival after allogeneic hematopoieticcell transplantation during a period of significantly increased use, older recipientage, and use of unrelated donors. / T Hahn, PL Jr McCarthy, A Hassebroek et al //J Clin Oncol.—2013. —Vol.31—P.2437-2449.61.Hardy, J.M. Photo-induced graft-versus-host disease./ JM Hardy, MCMarguery, A Huynh et al. // Photodermatol Photoimmunol Photomed. — 2016. —Vol.32(5-6) —P.291-29562.Hillen, U. Progressive improvement in cutaneous and extracutaneouschronic graft-versus-host disease after a 24-week course of extracorporealphotopheresis-results of a crossover randomized study./ U Hillen, HT Greinix, Kvan Besien et al. //Biol Blood Marrow Transplant.
— 2011. —Vol.17(12) —1775178263. Hillen, U. Consensus on performing skin biopsies, laboratory workup,evaluation of tissue samples and reporting of the results in patients with suspectedcutaneous graft-versus-host disease./ U Hillen, P Häusermann, D Massi et al. // JEur Acad Dermatol Venereol. — 2014. —Sep 30. —94864.Inamoto, Y. Incidence, risk factors, and outcomes of sclerosis in patientswith chronic graft-versus-host disease./ Y Inamoto, BE Storer, EW Petersdorf etal.// Blood—2013. —Vol.121 —P.5098-5103.14965.Jacobsohn, D.A. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from theChronic GVHD Consortium./DA Jacobsohn, BF Kurland, J Pidala et al.
//Blood—2012. —Vol.120(13) —P.2545-2552.66. Jang, S. Chronic graft-versus-host disease mimicking psoriasis in a patient withhemophagocytic lymphohistiocytosis./ S Jang, IS Kim, SW Youn//Ann Dermatol.— 2016.—Vol.28(1) —P.90-93.67.Kaminska-Winciorek, G. Dermoscopic Follow-Up of the Skin towardsAcute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic StemCell Transplantation./ G Kaminska-Winciorek, T Czerw, T Kruzel, S Giebel//BioMed Research International— 2016.
— Vol. 2016— Article ID 4535717.68.Kavand, S. Cutaneous manifestations of graft-versus-host disease: role of thedermatologis/ S Kavand, JS Lehman, S Hashmi et al. //Int J Dermatol.—2017.—Vol.56(2) —P.131-140.69.Lacouture,MarioE.DermatologicPrinciplesandPracticeinOncology.Conditions of the Skin, Hair, and Nails in Cancer Patients / LacoutureMario E. —Wiley Blackwell, 2014.—456p.70.Lazaryan, A. Evolving concepts in prognostic scoring of chronic GvHD/ ALazaryan, M Arora //Bone Marrow Transplant.
—2017. —Vol.52 (10) —P.13611366.71.Lee, S.J. Classification systems for chronic graft-versus-host disease/ SJ Lee// Blood—2017 —Vol.129(1) —P.30-37.72. Lee, S.J. Success of Immunosuppressive Treatments in Patients with ChronicGraft-versus-Host Disease./ SJ Lee, TD Nguyen, L Onstad et al. // Biol BloodMarrow Transplant. — 2018. —Vol.24 (3) —P. 555-562.15073.LeRoy, E.C. Criteria for the classification of early systemic sclerosis./ ECLeRoy, TA Jr Medsger//J Rheumatol.
—2001 —Vol.28 —P.1573–157674. Maldonado, M.S. Compassionate use of ruxolitinib in acute and chronic graftversus host disease refractory both to corticosteroids and extracorporealphotopheresis. Experimental Hematology & Oncology. 2017. —Dec.875.Martin, P.J. An endpoint associated with clinical benefit after initialtreatment for chronic graft-versus-host disease/ PJ Martin, BE Storer, Y Inamoto etal.//Blood —2017.
—Vol.130(3) —P.360-367.76.Mazzotti, N.G. Assessment of nailfold capillaroscopy in systemic sclerosisby different optical magnification methods/ NG Mazzotti, M Bredemeier, CVBrenol et al.//Clin Exp Dermatol. —2014. — Vol.39(2) —P.135-141.77. McCarthy, P.L. Jr. Trends in use of and survivalafter autologous hematopoieticcell transplantation in North America,1995-2005: significant improvement insurvival for lymphoma andmyeloma during a period of increasing recipient age/PL Jr McCarthy, T Hahn, A Hassebroek et al.// Biol Blood Marrow Transplant. —2013. —Vol.19 №7 —P.1116-1123.78.Milam, P.B. Psoriasiform graft-versus-host disease distributed along Blaschko'slines/ PB Milam, SV Vasu, AA Gru, BH Kaffenberger // J Cutan Pathol. —2017—Vol.
44(10) —P.882-88679.Minoo, Battiwalla National Institutes of Health Hematopoietic CellTransplantation Late Effects Initiative: Developing Recommendations to ImproveSurvivorship and Long-Term Outcomes/ Battiwalla Minoo, Hashmi Shahrukh,Majhail Navneet et al. // Biology of Blood and Marrow Transplantation— 2016.
—Vol. 23№1—P.6-915180. Motta, A. Immunohistopathological characterization and the impact of topicalimmunomodulatory therapy in oral chronic GVHD: a pilot study/ A Motta, QZhan, A Larson at all // Oral Dis. —2017. — Dec 281. Murali, A.R. Graft versus Host Disease After Liver Transplantation in Adults:A Case series, Review of Literature, and an Approach to Management/ AR Murali,S Chandra, Z Stewart, et al. // Transplantation— 2016.—Vol.100(12) —P.26612670.82. Peyraga, G. Treatment of cutaneous and/or soft tissue manifestations ofcorticosteroids refractory chronic graft versus host disease (cGVHD) by a totalnodal irradiation (TNI)/ G Peyraga, T Lizee, P Gustin et al.
//Clin Transplant. —2017. — Vol.31(4) —Apr.1483. Pizzorni, C. Nailfold capillaroscopic parameters and skin telangiectasiapatterns in patients with systemic sclerosis/ C Pizzorni, AR Giampetruzzi, CMondino et al.//Microvasc Res. — 2017. — Vol.111 —P.20-24.84. Qayed, M. Influence of Age on Acute and Chronic GVHD in ChildrenUndergoing HLA-Identical Sibling Bone Marrow Transplantation for AcuteLeukemia: Implications for Prophylaxis./ M Qayed, T Wang, MT Hemmer et al. //Biol Blood Marrow Transplant. — 2018. — Vol.24(3) —P.521-52885.Reinfjell, T. A Review of Demographic, Medical, and Treatment VariablesAssociated with Health-Related Quality of Life (HRQOL) in Survivors ofHematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT)during Childhood/ T Reinfjell, M Tremolada, LK Zeltzer // Front Psychol.
—2017.—Vol.8—P.1-9.86.Rennie, D. Nailfold dermatoscopy in general practice/ D Rennie //: AustFam Physician —2015. —Vol 44(11) —P.809-1215287. Schneiderman, J. Extracorporeal photopheresis: cellular therapy for thetreatment of acute and chronic graft-versus-host disease/ J Schneiderman//Hematology Am Soc Hematol Educ Program. — 2017. — Vol.(1) —P.639-64488..Socié,G.Acuteandchronicskingraft-versus-hostdisease-pathophysiological aspects/ G Socié, R Peffault de Latour, JD Bouziz, M Rybojad// Curr Probl Dermatol.
— 2012. —Vol. 43—P.91-10089.Solomon, S.R. Current Graft-versus-Host Disease-Free, Relapse-FreeSurvival: A Dynamic Endpoint to Better Define Efficacy after AllogenicTransplant./ SR Solomon, C Sizemore, X Zhang et al.// Biol Blood MarrowTransplant. — 2017— Vol. 23—P.1208-121490.
Strong Rodrigues , K. Cutaneous Graft-Versus-Host Disease: Diagnosis andTreatment/ K Strong Rodrigues, C Oliveira-Ribeiro, S de Abreu Fiuza Gomes, RKnobler // Am J Clin Dermatol. — 2018—Vol.19—P.33–5091.Tandra ,A. Low dose anti-thymocyte globulin reduces chronic graft-versus-hostdisease incidence rates after matched unrelated donor transplantation/ A Tandra, FCovut, B Cooper et al.
// Leuk Lymphoma —2017.— Dec 4—P.1-892.Taverna,F.Biologicalqualitycontrolforextracorporealphotochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags ofchronic GvHD patients/ F Taverna, P Coluccia, F Arienti et al. //J Clin Apher. —2015.—Vol.30(3) —P.162-170.93.Taylor, A.T. Acute graft versus host disease following liver transplantation: theenemy within./ A.T. Taylor, P Gibbs, J.A. Bradley // Am J Transpl.—2004. —Vol.4 —P.466–474.94.Vasconcelos, L. Chronic graft-versus-host disease: clinical presentation ofmultiple lesions of lichenoid and atrophic pattern./L Vasconcelos, EC Vieira, EMMinicucci et al//An Bras Dermatol.
— 2013. —Vol.88(5) —P.799-802.15395. Vassallo, C. Lichenoid cutaneous chronic GvHD following Blaschko lines/ CVassallo, F Derlino, F Ripamonti et al.//Int J Dermatol.— 2014. —Vol.53(4) —P.473-475.96.Villarreal Villarreal, C.D. Cutaneous graft-versus-host disease afterhematopoietic stem cell transplant - a review/ C.D Villarreal Villarreal, J.C. JaimePérez, J.
Salas-Alanis et al.//Anais Brasileiros de Dermatologia—2016. —Vol.91(3) —P.336-343.97.Villarrubiaa, V.G. Barrera epidermica y nutrition lipidica^personalizando ladermatitis atopica.I. Enzimas regulatoras y proteinas fijadoras de acidos grasos(FABP) en la conexion PRAR e immunologica / V.G. Villarrubiaa, S. VidalAsensib, V.
Pérez-Bañascoc et al. // Actas Dermosifiliogr —2010. —; Vol. 101№7—P.585-9998.Wei, J. Atopic dermatitis-like presentation of graft-versus-host disease: anovel form of chronic cutaneous graft-versus-host disease/ Y Wei J Zhang, H Xu, JJin, J Zhang//J Am Acad Dermatol. —2013. —Vol.69(1) —P.34-39.99.Wolff, D. Histopathological diagnosis of graft-versus-host disease of theskin-an interobserver comparison/ D Wolff, H Greinix, U Hillen et al.// J Eur AcadDermatol Venereol. —2014.—Vol. 28(7) —P.915-924.100.World Marrow Donor Association [электронный ресурс]// Режимдоступа: https://www.wmda.info/101.
Wu, PA. Cutaneous graft-versus-host disease-clinical considerations andmanagement/ PA Wu, EW Cowen.//Curr Probl Dermatol. —2012. —Vol.43—P.101-115.102. Ziemer, M. Histopathological diagnosis of graft-versus-host disease of theskin: an interobserver comparison./ M Ziemer, P Haeusermann, A Janin et al.\J EurAcad Dermatol Venereol., — 2014.—Vol.8(7) —P.915-24.154103.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
